Healthcare2 min reading time

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Ars Technica
Read full post
Moderna's mRNA flu vaccine, mFLUSIVA, has received FDA approval, marking a milestone for mRNA technology in flu prevention. The vaccine offers faster production and potential benefits over traditional flu shots but faces uncertainty due to a stalled CDC advisory panel and unclear insurance coverage.

More in Healthcare

Google DeepMind Releases AlphaGenome Atlas Mapping 9 Billion Human DNA

Forbes
Healthcare3 min read

Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his

TechCrunch

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources